Document is current
Any future updates will be listed below
-
Authors
Adigweme, Ikechukwu
Akpalu, Edem
Yisa, Mohammed
Donkor, Simon
Jarju, Lamin B.
Danso, Baba
Mendy, Anthony
Jeffries, David
Njie, Abdoulie
Bruce, Andrew
Royals, Michael
Goodson, James L.
Prausnitz, Mark R.
McAllister, Devin
Rota, Paul A.
Henry, Sebastien
Clarke, Ed https://orcid.org/0000-0002-7785-0340
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation
- License Information
-
More Information
Article History
Received: 17 February 2022
Accepted: 24 June 2022
First Online: 14 September 2022
Declarations
:
: The trial requires the approval of The Gambia Government/MRC Joint Ethics Committee and the LSHTM Research Ethics Committee (reference LEO 22420). Regulatory approval is required from the Gambian Medicines Control Agency which is the national regulatory agency in The Gambia. Written or thumb-printed informed consent for study participation will be obtained from all participants/the parents of study participants.
: A copy of the informed consent documents for the trial may be made available on request.
: SH, MRP, DM and MR are employees or consultants of Micron Biomedical, Inc — the developers of the MRV-MNP. No other authors declare any conflicts of interest.
